Short report: Pharmacokinetics of dihydroartemisinin in a murine malaria model

American Journal of Tropical Medicine and Hygiene

Volumn 78, Issue 4, 2008, Pages 641-642

  Batty, Kevin T ^a   Gibbons, Peter L ^a   Davis, Timothy M E ^b   Ilett, Kenneth F ^b  

^a CURTIN UNIVERSITY   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CITRIC ACID; DIHYDROARTEMISININ; DIMETHYL SULFOXIDE; GLUCOSE; NITROGEN; PHENOBARBITAL; PHOSPHATE; POLYSORBATE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; DIHYDROQUINGHAOSU;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; BLOOD SMEAR; BODY WEIGHT; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG HALF LIFE; HEMODILUTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INOCULATION; MALARIA; MALE; MOUSE; NONHUMAN; PARASITEMIA; ANIMAL; BLOOD; DISEASE MODEL; HUMAN; METABOLIC CLEARANCE RATE; RAT; SPECIES DIFFERENCE;

MURINAE; MUS;

ANIMALS; ANTIMALARIALS; ARTEMISININS; DISEASE MODELS, ANIMAL; HUMANS; MALARIA; METABOLIC CLEARANCE RATE; MICE; RATS; SPECIES SPECIFICITY;

EID: 45349083314     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2008.78.641     Document Type: Article

References (19)

1. Davis TM, Karunajeewa HA, Ilett KF, 2005. Artemisinin-based combination therapies for uncomplicated malaria. Med J Aust 182: 181-185.
2. Kremsner PG, Krishna S, 2004. Antimalarial combinations. Lancet 364: 285-294.
3. Ilett KF, Batty KT, 2005. Artemisinin and its derivatives. Yu VL, Edwards G, McKinnon PS, Peloquin C, Morse GD, eds. Antimicrobial Therapy and Vaccines, Vol. II: Antimicrobial Agents. Baltimore: Williams & Wilkins, 981-1001.
4. White NJ, 2002. The assessment of antimalarial drug efficacy. Trends Parasitol 18: 458-464.
5. International Artemisinin Study Group, 2004. Artesunate combinations for treatment of malaria: meta-analysis. Lancet 363: 9-17.
6. Peters W, Robinson BL, 1999. Malaria. Zak O, Sande MA, eds. Handbook of Animal Models of Infection. San Diego: Academic Press, 757-773.
7. China Cooperative Research Group, 1982. Metabolism and pharmacokinetics of qinghaosu and its derivatives. J Trad Chin Med 2: 25-30.
8. Li QG, Peggins JO, Fleckenstein LL, Masonic K, Heiffer MH. Brewer TG, 1998. The pharmacokinetics and bioavailability of dihydroartemisinin, arteether, artemether, artesunic acid and artelinic acid in rats. J Pharm Pharmacol 50: 173-182.
9. Rajanikanth M, Madhusudanan KP, Gupta RC, 2003. An HPLC-MS method for simultaneous estimation of α,β-arteether and its metabolite dihydroartemisinin, in rat plasma for application to pharmacokinetic study. Biomed Chromatogr 17: 440-446.
10. Sabarinath S, Madhusudanan KP, Gupta RC, 2005. Pharmacokinetics of the diastereomers of arteether, a potent antimalarial drug, in rats. Biopharm Drug Dispos 26: 211-223.
11. Li Q, Xie LH, Si Y, Wong E, Upadhyay R, Yanez D, Weina PJ, 2005. Toxicokinetics and hydrolysis of artelinate and artesunate in malaria-infected rats. Int J Toxicol 24: 241-250.
12. Xing J, Yan HX, Zhang SQ, Ren G, Gao Y, 2006. A high-performance liquid chromatography/tandem mass spectrometry method for the determination of artemisinin in rat plasma. Rapid Commun Mass Spectrom 20: 1463-1468.
13. Xing J, Yan HX, Wang RL, Zhang LF, Zhang SQ, 2007. Liquid chromatography-tandem mass spectrometry assay for the quantitation of β-dihydroartemisinin in rat plasma. J Chromatogr B 852: 202-207.
14. Lewis SM, Bain BJ, Bates I, 2006. Practical Haematology. Tenth edition. Philadelphia: Churchill Livingstone.
15. Batty KT, Davis TM, Thu LT, Binh TQ, Anh TK, Ilett KF, 1996. Selective high-performance liquid chromatographic determination of artesunate and α- and β-dihydroartemisinin in patients with falciparum malaria. J Chromatogr B 677: 345-350.
16. Bailer AJ, 1988. Testing for the equality of area under the curves when using destructive measurement techniques. J Pharmacokinet Biopharm 16: 303-309.
17. Yuan J, 1993. Estimation of variance for AUC in animal studies. J Pharm Sci 82: 761-763.
18. Binh TQ, Ilett KF, Batty KT, Davis TME, Hung NC, Powell SM, Thu LTA, Thien HV, Phuong HL, Phuong VDB, 2001. Oral bioavailability of dihydroartemisinin in Vietnamese volunteers and in patients with falciparum malaria. Br J Clin Pharmacol 51: 541-546.
19. Batty KT, Ilett KF, Powell SM, Martin J, Davis TME, 2002. Relative bioavailability of artesunate and dihydroartemisinin: investigations in the isolated perfused rat liver and in healthy Caucasian volunteers. Am J Trop Med Hyg 66: 130-136.